Acne Treatment Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Acne Treatment Market: By Device Type (Photodynamic, Laser, Radiofrequency, Others), By End-User Industry (Hospitals, Clinics, Salon & Spa, Individual Home, Others), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Acne Treatment Market Size is estimated to be valued at USD 1,217.3 million in 2022 and is expanded to grow at a significant CAGR of 8.2% over 2022-2028. The rising psychological problems of acne among youth or across age groups are critical factors for this market’s growth. Consumers are looking for safe and cost-effective options for acne treatment. Growing demand for quick and safe treatments and solid results are some of the factors projected to drive the market in the forecasted period. Acne’s constant prevalence worldwide is expected to boost the growth of the acne treatment market. Acne clearing devices aid in the healing process when used in conjunction with drugs, allowing the body to effectively treat acne, which is anticipated to drive the growth of the acne treatment market. The growing inclination of consumers toward acne treatment devices that are convenient to use at home creates an opportunity for marketers. Individuals aged 12 to 30 years old have the highest prevalence of acne, and the growing number of people in this age group is driving the market for acne treatment devices. In the acne treatment market, the salon & spa, and clinic segments are expected to contribute the highest revenue share of 36.7% in 2020. The growing number of salons with innovative treatments, increasing sedentary lifestyles, and raising awareness about upcoming trends in acne treatments may boost the market.

Recent Market Developments:

In March 2022, CUTERA, INC., a leading provider of dermatology solutions, announced the U.S. Food and Drug Administration’s 510(k) clearance of AviClear, the first and only energy-based device to receive this designation for the treatment of mild, moderate, and severe acne.

In November 2021, Sun Pharmaceutical Industries Limited announced the availability of WINLEVI (clascoterone) cream 1% in the United States (U.S). A first-in-class topical androgen receptor inhibitor, WINLEVI, was approved by the U.S. Food and Drug Administration (FDA) in August 2020 for the topical treatment of acne vulgaris in patients 12 years of age and older.

Acne Treatment Market

MARKET SUMMARY
-
8.2% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 8.2%
  • Largest Market– North America
  • Fastest Growing Market– Asia Pacific

Acne Treatment Market

  • The acne treatment market report gives a comprehensive outlook on acne treatment options across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA).
  • The report gives historical, current, and future market sizes (US$ Mn) of product types, medication type, acne types, route of administration, distribution channels, and geographic regions.
Market Key Players
  • Allergan plc.
  • Bayer AG
  • Johnson and Johnson
  • Cipher Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Ltd.
Acne Treatment Market

Dynamics

The global acne treatment market is mainly driven by rising disposable income, the high incidence rate of acne across regions, increased consumer spending for such treatments, and growing skin consciousness in the millennial age group. Cheap products & traditional therapies, and high treatment costs & side effects will hinder the market growth.


North-America got significant share

Acne Treatment Market

North America acne treatment market held the highest market share of 32.8% in 2021. Growth in the North American market is primarily driven by growth in the USA region. The rising psychological problems of acne among American youth are critical factors for developing this market. In addition, Europe will be the second-largest shareholder due to the region's growing patient pool, significant companies' robust investment in R&D for drugs used to treat dermatological conditions, and enhanced adoption of advanced treatment products.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Segmentation

Acne Treatment Market


Location

GEOGRAPHY

Frequently Asked Questions

The acne treatment market is projected to expand at a CAGR of 8.2% during the forecast period.

Asia Pacific is the fastest-growing region for acne treatment market

Allergan plc. , Bayer AG, GlaxoSmithKline plc, Cipher Pharmaceuticals Inc.


Report

Table Of Content

  1. Research Methodology
    • Secondary and Primary research
      • Secondary Sources
      • Primary Sources
    • Market Revenue Estimation Methodology
    • Key Assumptions
    • Acronyms
  2. Scope of Study
    • Market Definition
    • Objective of the Research
    • Regions covered in the study
  3. Executive summary
  4. Global Acne Treatment Market Dynamics
    • Drivers
      • Economic Drivers
      • Demand Side Drivers
      • Supply Side Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
  5. Unique Features of the Report
    • Competition analysis
    • Regulatory landscape
    • PESTLE analysis
    • Porter’s analysis
  6. Global Acne Treatment Market Analysis, By Product Type, 2013 – 2017 and Forecast, 2018 – 2024
    • Antibiotics
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Retinoid Therapy
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Hormonal Drugs
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Anti-Inflammatory Drugs
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Chemical Peels
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Radiofrequency Devices
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Laser Devices
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
  1. Global Acne Treatment Market Analysis, By Medication Type, 2013 – 2017 and Forecast, 2018 – 2024
    • Prescription
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • OTC
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
  1. Global Acne Treatment Market Forecast, By Acne Type Analysis, 2013 – 2017 and Forecast, 2018 – 2024
    • Inflammatory Acne
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Non-Inflammatory Acne
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
  1. Global Acne Treatment Market Forecast, By Route of Administration Analysis, 2013 – 2017 and Forecast, 2018 – 2024
    • Oral
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Topical
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Parenteral
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
  1. Global Acne Treatment Market Forecast, By Distribution Channel Analysis, 2013 – 2017 and Forecast, 2018 – 2024
    • Hospitals
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Clinics
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Retail Pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Online Pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Drug Stores
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Retail Stores
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
  1. Acne Treatment Market Analysis, By Region, 2013 – 2017 and Forecast, 2018 – 2024
    • North America Acne Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
      • Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
        • Antibiotics
        • Retinoid Therapy
        • Hormonal Drugs
        • Anti-Inflammatory Drugs
        • Chemical Peels
        • Radiofrequency Devices
        • Laser Devices
      • Medication Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
        • Prescription
        •  OTC
      • Acne Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
        •  Inflammatory Acne
        •  Non-Inflammatory Acne
      • Route of Administration Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
        •  Oral
        •  Topical
        •  Parenteral
      • Distribution Channel Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
        •  Hospitals
        • Clinics
        • Retail Pharmacies
        •  Online Pharmacies
        • Drug Stores
        •  Retail Stores
      • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
        •  U.S.
        •  Canada
      • Europe Acne Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
      • Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
        • Antibiotics
        • Retinoid Therapy
        • Hormonal Drugs
        • Anti-Inflammatory Drugs
        • Chemical Peels
        • Radiofrequency Devices
        • Laser Devices
      • Medication Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
        • Prescription
        •  OTC
      • Acne Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
        •  Inflammatory Acne
        • Non-Inflammatory Acne
      • Route of Administration Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
        •  Oral
        •  Topica
        •  Parenteral
      • Distribution Channel Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
        • Hospitals

Report

Company Profile

  • GlaxoSmithKline plc (Stiefel Laboratories Inc.) (U.K)
  • Nestlé (Galderma S.A.) (Switzerland)
  • Valeant Pharmaceutical International, Inc. (Canada)
  • Johnson and Johnson (U.S)
  • Allergan plc. (Ireland)
  • Cipher Pharmaceuticals Inc. (Canada)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Bayer AG (Germany)

Description

Acne Treatment Market Size is estimated to be valued at USD 1,217.3 million in 2022 and is expanded to grow at a significant CAGR of 8.2% over 2022-2028. The rising psychological problems of acne among youth or across age groups are critical factors for this market’s growth. Consumers are looking for safe and cost-effective options for acne treatment. Growing demand for quick and safe treatments and solid results are some of the factors projected to drive the market in the forecasted period. Acne’s constant prevalence worldwide is expected to boost the growth of the acne treatment market. Acne clearing devices aid in the healing process when used in conjunction with drugs, allowing the body to effectively treat acne, which is anticipated to drive the growth of the acne treatment market. The growing inclination of consumers toward acne treatment devices that are convenient to use at home creates an opportunity for marketers. Individuals aged 12 to 30 years old have the highest prevalence of acne, and the growing number of people in this age group is driving the market for acne treatment devices. In the acne treatment market, the salon & spa, and clinic segments are expected to contribute the highest revenue share of 36.7% in 2020. The growing number of salons with innovative treatments, increasing sedentary lifestyles, and raising awareness about upcoming trends in acne treatments may boost the market.

Recent Market Developments:

In March 2022, CUTERA, INC., a leading provider of dermatology solutions, announced the U.S. Food and Drug Administration’s 510(k) clearance of AviClear, the first and only energy-based device to receive this designation for the treatment of mild, moderate, and severe acne.

In November 2021, Sun Pharmaceutical Industries Limited announced the availability of WINLEVI (clascoterone) cream 1% in the United States (U.S). A first-in-class topical androgen receptor inhibitor, WINLEVI, was approved by the U.S. Food and Drug Administration (FDA) in August 2020 for the topical treatment of acne vulgaris in patients 12 years of age and older.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX